Tan-Torres T
Clinical Epidemiology Unit, College of Medicine, University of the Philipines, Manila.
World Health Forum. 1995;16(1):74-6.
Although developing countries can ill afford to make the wrong choice of technology, they usually find it difficult if not impossible to support an adequate technology assessment programme. Much of the available information on the efficacy of various products is valid for other countries, but factors such as epidemiology, cost-effectiveness and acceptability also have to be taken into account, and these vary considerably from one setting to another. There is therefore a strong case for developing national programmes as quickly as possible.
尽管发展中国家承受不起选错技术的后果,但它们通常发现,即便不是完全不可能,也很难支持一个足够的技术评估项目。关于各种产品功效的现有信息大多对其他国家有效,但诸如流行病学、成本效益和可接受性等因素也必须考虑在内,而这些因素在不同环境中差异很大。因此,有充分理由尽快制定国家项目。